Genelink Inc. logo

Genelink Inc. (GNLKQ)

Market Closed
11 Aug, 20:00
OTC PINK OTC PINK
$
0. 00
0
0%
$
10.6K Market Cap
- P/E Ratio
- Div Yield
500 Volume
0 Eps
$ 0
Previous Close
Add Transaction
Day Range
0 0
Year Range
0 0
Want to track GNLKQ and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

GNLKQ closed yesterday higher at $0, an increase of 0% from Monday's close, completing a monthly increase of 0% or $0. Over the past 12 months, GNLKQ stock gained 300%.
GNLKQ is not paying dividends to its shareholders.
The last earnings report, released on Nov 14, 2013, missed the consensus estimates by -0.002%. On average, the company has fell short of earnings expectations by -0.0016%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on one exchange.

GNLKQ Chart

People also search for

Decker Manufacturing Corporation
$ 57.01
0%
Cannabix Technologies Inc.
$ 0.38
-1.8088%
VicapSys Life Sciences Inc.
$ 1.45
0%
Nuo Therapeutics Inc.
$ 0.85
0%
Quantumzyme Corp.
$ 0.8
+33.3333%

Genelink Inc. (GNLKQ) FAQ

What is the stock price today?

The current price is $0.00.

On which exchange is it traded?

Genelink Inc. is listed on OTC PINK.

What is its stock symbol?

The ticker symbol is GNLKQ.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 10.6K.

Has Genelink Inc. ever had a stock split?

No, there has never been a stock split.

Genelink Inc. Profile

Biotechnology Industry
Healthcare Sector
Bernard L. Kasten Jr. CEO
OTC PINK Exchange
36870F107 CUSIP
US Country
14 Employees
- Last Dividend
- Last Split
- IPO Date

Overview

GeneLink, Inc. is a pioneer in the genetic personalization health industry, offering a unique approach to wellness and skincare through its innovative DNA assessment services. Founded in 1994, the company is headquartered in Orlando, Florida, and has dedicated itself to integrating scientific advancements into personalized health solutions. By focusing on genetic predispositions, GeneLink seeks to empower individuals with tailored wellness strategies, highlighting its commitment to the intersection of science and personalized care.

Products and Services

  • 12-gene DNA Assessment Services

    This flagship service by GeneLink, Inc. leverages advanced genetic testing technology to analyze 12 specific genes associated with health and wellness. Through this assessment, the company provides personalized insights into an individual's genetic predispositions, offering a bespoke roadmap to optimized health and well-being. This service underlines the company's belief in a scientific, personalized approach to health care, providing consumers with actionable data based on their unique genetic makeup.

  • Health Custom Supplements

    Building on the insights gleaned from the DNA assessment, GeneLink offers customized nutritional supplements tailored to the individual's genetic needs. These specially formulated supplements are designed to address any dietary gaps or specific health concerns identified through the DNA assessment, ensuring that each client receives a personalized supplementation regimen that aligns with their genetic profile and wellness goals.

  • Line of Skin Care Products

    Extending its personalized health services to skincare, GeneLink, Inc. has also developed a proprietary line of skin care products. Formulated based on genetic insights, these products focus on providing targeted skincare solutions that cater to the specific needs and concerns indicated by an individual's genetic assessment. From anti-aging to hydration and beyond, GeneLink's skincare offerings aim to revolutionize the way consumers approach their skin health, delivering personalized care for maximum efficacy.

Contact Information

Address: 8240 Exchange Drive
Phone: 407-680-1150